Sponsored by
This exciting clinical trial has recently opened for patients with relapsed or refractory Glioblastomas. The Musella Foundation has funded early work on this drug, and we had a webinar about it. See https://virtualtrials.org/video2021.cfm?video=202105 for information about how the drug works!